Jagsonpal Pharmaceuticals Ltd.
Snapshot View

View in App

Prices View details

294.00 +2.30 ▲0.8%

24 June 2022, 04:01:00 PM
Volume: 2,341

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.jagsonpal.com
Market Cap 768.52 Cr.
Enterprise Value(EV) 744.07 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 7.48 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 39.23 Trailing Twelve Months Ending 2022-03
Industry PE 29.69 Trailing Twelve Months Ending 2022-03
Book Value / Share 46.96 Trailing Twelve Months Ending 2022-03
Price to Book Value 6.25 Calculated using Price: 293.35
Dividend Yield 1.36 Period Ending 2021-03
No. of Shares Subscribed 2.62 Cr. 26,198,000 Shares
FaceValue 5
Company Profile
In 1964 Jagsonpal started from humble beginnings with Jagmohan S. Kochhar operating a chemists shop in Delhi. Soon he expanded into making formulations. Mr. Kochhar's vision was to spread health and healing in India on a larger scale. He was at the helm of the company from its inception, through the startup phase. Even though Jagsonpal was a small business at the time, his vision was to create one of India's premiere pharmaceutical companies.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
+0.79%
1 Week
+7.36%
1 Month
-4.50%
3 Month
-1.36%
6 Month
+88.76%
1 Year
+99.39%
2 Year
+652.88%
5 Year
+693.52%
10 Year
+2250.12%

Ratios View Details

9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) 2.15 2.47 1.35 3.65 12.32 -12.01 7.72 7.88 15.70
Return on Capital Employed (%) 6.42 6.57 4.93 7.32 14.26 -10.52 9.80 9.46 19.43
Return on Assets (%) 1.19 1.37 0.75 2.08 7.86 -8.48 5.43 5.53 10.90

Balance Sheet View Details

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 98 99 95 98 110 98 104 111 122 131
Non Curr. Liab. 5 4 4 4 3 3 3 3 2 3
Curr. Liab. 50 54 55 57 29 29 28 35 40 34
Minority Int.
Equity & Liab. 153 156 154 159 143 130 136 149 164 168
Non Curr. Assets 66 65 58 58 33 35 38 52 44 58
Curr. Assets 87 91 96 101 110 95 98 96 120 111
Misc. Exp. not W/O
Total Assets 153 156 154 159 143 130 136 149 164 168

Profit Loss View Details

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. TTM
Net Sales 166 144 138 143 144 127 167 159 188 226
Other Income 0 0 0 1 0 0 1 3 4 3
Total Income 167 144 138 144 144 127 168 161 192 229
Total Expenditure -156 -133 -129 -132 -138 -138 -157 -150 -169 -200
PBIDT 10 11 9 12 6 -11 11 11 23 29
Interest -5 -5 -4 -5 -3 -1 -1 -1 -1 0
Depreciation -3 -3 -3 -3 -2 0 -1 -1 -1 -2
Taxation -1 0 -1 -1 -3 0 -2 -2 -5 -8
Exceptional Items 13
PAT 2 2 1 3 12 -12 7 8 17 20
Adjusted EPS 1 1 0 1 5 -4 3 3 7 7

Cash Flow View Details

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 7 12 8 4 9 -3 -2 31 12 28
Cash Fr. Inv. -5 -3 -1 0 -2 41 -3 -1 -11 -2
Cash Fr. Finan. 0 -8 -4 -1 -6 -34 -1 -6 -2 -7
Net Change 3 0 2 2 1 5 -6 24 -1 19
Cash & Cash Eqvt 10 10 13 15 16 20 15 39 40 59

Shareholding Pattern View Details

9 Qtrs 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%)
Promoter 70.34 70.34 70.34 70.34 70.34 70.34 70.34 70.34 68.71
Public 29.66 29.66 29.66 29.66 29.66 29.66 29.66 29.66 31.29
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Wed, 22 Jun 2022
Post Offer Advertisement
Centrum Capital Ltd ("Manager to the Offer") has submitted to BSE a copy of Post Offer Advertisement in accordance with Regulation 18(12) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations 2011 as amended for the attention of the public shareholders of Jagsonpal Pharmaceuticals Ltd ("Target Company").
Tue, 21 Jun 2022
Disclosure of Voting results of EGM (Regulation 44(3) of SEBI (LODR) Regulations 2015)
Jagsonpal Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of EGM under Regulation 44(3) of SEBI (LODR) Regulations 2015. Kindly Click here
Sat, 18 Jun 2022
Voting Results
EGM-Voting Results

Technical Scans View Details

Fri, 24 Jun 2022
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Opening at High Opening at High
High Increase 6 Months High Increase 6 Months
High Increase 1 Year High Increase 1 Year
High Increase 2 Years High Increase 2 Years

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 197,729.19 824.10 -0.1%
Divi's Laboratories Ltd. 97,465.46 3,671.45 +0.1%
Cipla Ltd. 75,288.48 933.05 +0.0%
Dr. Reddy's Laboratories Ltd. 71,702.79 4,308.00 +0.3%
Apollo Hospitals Enterprise Ltd. 55,150.04 3,835.60 -0.4%
Torrent Pharmaceuticals Ltd. 48,693.19 2,877.70 +0.8%
Gland Pharma Ltd. 42,987.55 2,610.75 +0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 60.42 824.10 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 32.92 3,671.45 +0.1%
Cipla Ltd. Consolidated 2022-03 29.92 933.05 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 32.85 4,308.00 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 52.24 3,835.60 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 62.67 2,877.70 +0.8%
Gland Pharma Ltd. Consolidated 2022-03 35.48 2,610.75 +0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 4.12 824.10 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8.31 3,671.45 +0.1%
Cipla Ltd. Consolidated 2022-03 3.61 933.05 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 3.73 4,308.00 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 9.78 3,835.60 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8.18 2,877.70 +0.8%
Gland Pharma Ltd. Consolidated 2022-03 6.01 2,610.75 +0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 0.08 824.10 -0.1%
Divi's Laboratories Ltd. Consolidated 2021-03 0.00 3,671.45 +0.1%
Cipla Ltd. Consolidated 2021-03 0.10 933.05 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,308.00 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 0.62 3,835.60 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 0.84 2,877.70 +0.8%
Gland Pharma Ltd. Consolidated 2021-03 0.00 2,610.75 +0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.98 824.10 -0.1%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 3,671.45 +0.1%
Cipla Ltd. Consolidated 2021-03 14.13 933.05 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,308.00 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 3.44 3,835.60 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 23.49 2,877.70 +0.8%
Gland Pharma Ltd. Consolidated 2021-03 20.97 2,610.75 +0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.98 824.10 -0.1%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 3,671.45 +0.1%
Cipla Ltd. Consolidated 2021-03 14.13 933.05 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,308.00 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 3.44 3,835.60 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 23.49 2,877.70 +0.8%
Gland Pharma Ltd. Consolidated 2021-03 20.97 2,610.75 +0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 33,498.14 824.10 -0.1%
Divi's Laboratories Ltd. Consolidated 2021-03 6,969.40 3,671.45 +0.1%
Cipla Ltd. Consolidated 2021-03 19,159.59 933.05 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,308.00 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 10,560.00 3,835.60 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 8,004.83 2,877.70 +0.8%
Gland Pharma Ltd. Consolidated 2021-03 3,462.88 2,610.75 +0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 2,284.68 824.10 -0.1%
Divi's Laboratories Ltd. Consolidated 2021-03 1,984.29 3,671.45 +0.1%
Cipla Ltd. Consolidated 2021-03 2,401.30 933.05 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,308.00 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 136.00 3,835.60 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 1,251.88 2,877.70 +0.8%
Gland Pharma Ltd. Consolidated 2021-03 996.96 2,610.75 +0.1%

FAQ's On Jagsonpal Pharmaceuticals Ltd.

Can I Buy Jagsonpal Pharma Shares now?
What is the Share Price of Jagsonpal Pharma?
What is the Relative Strength Index (RSI) Value of Jagsonpal Pharma?
What is the Market Capital (MCAP) of Jagsonpal Pharma?
What are the key metrics to analyse Jagsonpal Pharma?
What is the Price Performance of Jagsonpal Pharma?